Caricamento...
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It accounts for 15%–20% of all breast cancers and is associated with an aggressive evolution and poor outcomes with the maj...
Salvato in:
| Pubblicato in: | Int J Breast Cancer |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7661147/ https://ncbi.nlm.nih.gov/pubmed/33204535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8209173 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|